Mansour Salem, Giles Joshua, Nair Krishnan P S, Marshall Rebecca, Ali Ali, Arvaneh Mahnaz
Department of Automatic Control and Systems Engineering, University of Sheffield, Sheffield, UK.
Department of Neurology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.
J Neuroeng Rehabil. 2025 Apr 24;22(1):91. doi: 10.1186/s12984-025-01607-x.
We have created a groundbreaking telerehabilitation system known as Tele BCI-FES. This innovative system merges brain-computer interface (BCI) and functional electrical stimulation (FES) technologies to rehabilitate upper limb function following a stroke. Our system pioneers the concept of allowing patients to undergo BCI therapy from the comfort of their homes, while ensuring supervised therapy and real-time adjustment capabilities. In this paper, we introduce our single-arm clinical trial, which evaluates the feasibility and acceptance of this proposed system as a telerehabilitation solution for upper extremity recovery in stroke survivors.
The study involved eight chronic patients with stroke and their caregivers who were recruited to attend nine home-based Tele BCI-FES sessions (three sessions per week) while receiving remote support from the research team. The primary outcomes of this study were recruitment and retention rates, as well as participants perception on the adoption of technology. The secondary outcomes involved assessing improvements in upper extremity function using the Fugl-Meyer Assessment for Upper Extremity (FMA_UE) and the Leeds Arm Spasticity Impact Scale.
Seven chronic patients with stroke completed the home-based Tele BCI-FES sessions, with high retention (87.5%) and recruitment rates (86.7%). Although participants provided mixed feedback on setup ease, they found the system progressively easier to use, and the setup process became more efficient with continued sessions. Participants suggested modifications to enhance user experience. Following the intervention, a significant increase in FMA_UE scores was observed, with an average improvement of 3.83 points (p = 0.032). The observed improvement of 3.83 points in the FMA-UE score approaches the reported Minimal clinically important difference of 4.25 points for patients with chronic stroke.
This study serves as a proof of concept, showcasing the feasibility and acceptability of the proposed Tele BCI-FES system for rehabilitating the upper extremities of stroke survivors. While some participants demonstrated significant improvements in FMA-UE scores, these findings are not generalizable, as they were derived from a small-scale feasibility study. The results should be interpreted cautiously within the study's specific context. Additionally, the intervention was not compared to other therapeutic approaches, limiting conclusions regarding its relative effectiveness. To further validate the efficacy of the proposed Tele BCI-FES system, it is essential to conduct additional research with larger sample sizes and extended rehabilitation sessions. Moreover, future studies should include comparisons with other therapeutic approaches to better evaluate the relative effectiveness of this intervention. Trial registration This clinical study is registered at clinicaltrials.gov https://clinicaltrials.gov/study/NCT05215522 under the study identifier (NCT05215522) and registered with the ISRCTN registry https://doi.org/10.1186/ISRCTN42991002 (ISRCTN42991002).
我们创建了一个开创性的远程康复系统,称为远程脑机接口-功能性电刺激(Tele BCI-FES)。这个创新系统融合了脑机接口(BCI)和功能性电刺激(FES)技术,用于中风后上肢功能的康复。我们的系统开创了让患者在舒适的家中接受BCI治疗的概念,同时确保有监督的治疗和实时调整能力。在本文中,我们介绍了我们的单臂临床试验,该试验评估了这个提议的系统作为中风幸存者上肢恢复的远程康复解决方案的可行性和可接受性。
该研究招募了8名慢性中风患者及其护理人员,他们参加了9次基于家庭的Tele BCI-FES治疗课程(每周3次),同时接受研究团队的远程支持。本研究的主要结果是招募率和留存率,以及参与者对技术采用的看法。次要结果包括使用上肢Fugl-Meyer评估量表(FMA_UE)和利兹手臂痉挛影响量表评估上肢功能的改善情况。
7名慢性中风患者完成了基于家庭的Tele BCI-FES治疗课程,留存率(87.5%)和招募率(86.7%)都很高。尽管参与者对设置的难易程度反馈不一,但他们发现系统使用起来逐渐变得更容易,并且随着治疗课程的持续,设置过程变得更有效率。参与者建议进行改进以提升用户体验。干预后,观察到FMA_UE评分显著增加,平均提高了3.83分(p = 0.032)。FMA-UE评分中观察到的3.83分的改善接近报道的慢性中风患者最小临床重要差异4.25分。
本研究作为一个概念验证,展示了提议的Tele BCI-FES系统用于中风幸存者上肢康复的可行性和可接受性。虽然一些参与者的FMA-UE评分有显著改善,但这些发现不能推广,因为它们来自一项小规模的可行性研究。结果应在研究的特定背景下谨慎解释。此外,该干预未与其他治疗方法进行比较,限制了关于其相对有效性的结论。为了进一步验证提议的Tele BCI-FES系统的疗效,进行更大样本量和更长康复疗程的额外研究至关重要。此外,未来的研究应包括与其他治疗方法的比较,以更好地评估该干预的相对有效性。试验注册 本临床研究已在clinicaltrials.gov(https://clinicaltrials.gov/study/NCT05215522)上注册,研究标识符为(NCT05215522),并在ISRCTN注册库(https://doi.org/10.1186/ISRCTN42991002,ISRCTN42991002)上注册。